Skip to main content
Clinical Trials/NCT02368925
NCT02368925
Completed
Not Applicable

Clinical Trial to Evaluate Safety and Efficacy of Ultherapy™ System for Lifting Skin

Seoul National University Hospital1 site in 1 country18 target enrollmentMarch 2015
ConditionsWrinkles

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Wrinkles
Sponsor
Seoul National University Hospital
Enrollment
18
Locations
1
Primary Endpoint
Investigator Assessment of Improvement at 12 weeks post-treatment
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

Study is a prospective clinical trial to evaluate the efficacy of the Ulthera® System to improve Lifting Skin on the Neck. Changes from baseline in the FACE-Q Appraisal of Neck scale score and Global Aesthetic Improvement Scale scores will be assessed at study follow-up visits.

Detailed Description

Before Treatment: The subject's eligibility (inclusion/exclusion criteria) will be assessed, and all subjects will check the FACE-Q Appraisal of Neck scale score Treatment: The Investigator will apply to the eligible subject the Study Device Ultherapy™ System with 200\~260 lines of 3.0 and 4.5 probe respectively on the subject's neck. Post-Treatment: All subjects will visit the Institution at 12 weeks from the day of procedure, and will take photos of the neck. Efficacy evaluation will performed by the Photographic Evaluator.

Registry
clinicaltrials.gov
Start Date
March 2015
End Date
October 2015
Last Updated
10 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male or female, aged 30 to 65 years.
  • Subject in good health
  • Subjects who desire improvement in neck skin

Exclusion Criteria

  • Presence of an active systemic infectious disease
  • general disease or skin disorder in the area to be treated
  • Pregnant or lactating subjects
  • Previous episode of facial or neck surgery for wrinkle correction
  • Subjects who have aesthetic addiction, drug abuse, alcohol abuse
  • Subjects who were treated Botox or Filler at the neck area
  • Subjects who had Auto-Immune disease

Outcomes

Primary Outcomes

Investigator Assessment of Improvement at 12 weeks post-treatment

Time Frame: 12 weeks post-treatment

Investigator complete Global Aesthetic Improvement Scale at 12 weeks post-treatment by comparing subject's photographs

Secondary Outcomes

  • Subject Assessment of Improvement at 12 weeks post-treatment(12 weeks post-treatment)
  • Subjects' Assessment of Pain during treatment(Subjects were assessed for the duration of study treatment)

Study Sites (1)

Loading locations...

Similar Trials